Betulinic acid derivatives as HIV-1 antivirals

Trends in Molecular Medicine

Volumn 11, Issue 1, 2005, Pages 31-36

  Aiken, Christopher ^a   Chen, Chin Ho ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 O (3,3 DIMETHYLSUCCINYL)BETULIC ACID; 4 (8 BETULINOYLAMINOOCTANOYLAMINO) 3 HYDROXY 6 METHYLHEPTANOIC ACID; ANTIVIRUS AGENT; BETULIC ACID; CELASDIN B; ESCIN; FK 3000; GANODERIOL B; GARCIOSATERPENE DERIVATIVE; GEUMONOID; GLYCYRRHIZIC ACID; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; INTEGRACIDE DERIVATIVE; INTEGRASE; LANCILACTONE C; LH 15; LIMONOID; LIMONOID DERIVATIVE; MIMUSOPSIC ACID; NIGRANOIC ACID; OLEANOLIC ACID; PROTEINASE; RNA DIRECTED DNA POLYMERASE; TERPENE DERIVATIVE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; URSOLIC ACID;

ANTIVIRAL ACTIVITY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

ANTI-HIV AGENTS; HIV-1; HUMANS; TRITERPENES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 11844249942     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.11.001     Document Type: Review

References (50)

1. H. Nishaino Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds Cancer Res. 48 1988 5210 5215
2. H. Tokuda Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate Cancer Lett. 33 1986 279 285
3. H. Tsuda, and H. Okamoto Elimination of metabolic cooperation by glycyrrhetinic acid, an anti-tumor promoter, in cultured Chinese hamster cells Carcinogenesis 7 1986 1805 1807
4. J.F. Mayaux Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 3564 3568
5. F. Soler Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry J. Med. Chem. 39 1996 1069 1083
6. T. Fujioka Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids J. Nat. Prod. 57 1994 243 247
7. Y. Kashiwada Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents J. Med. Chem. 39 1996 1016 1017
8. F. Hashimoto Anti-AIDS agents - XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives Bioorg. Med. Chem. 5 1997 2133 2143
9. B. Labrosse Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41 J. Virol. 71 1997 8230 8236
10. S.L. Holz-Smith Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564 Antimicrob. Agents Chemother. 45 2001 60 66
11. T. Kanamoto Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation Antimicrob. Agents Chemother. 45 2001 1225 1230
12. T.C. Pierson, and R.W. Doms HIV-1 entry and its inhibition Curr. Top. Microbiol. Immunol. 281 2003 1 27
13. B. Labrosse Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region J. Virol. 74 2000 2142 2150
14. X. Yuan Conformation of gp120 determines the sensitivity of HIV-1 DH012 to the entry inhibitor IC9564 Virology 324 2004 525 530
15. S. Bar, and M. Alizon Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process J. Virol. 78 2004 811 820
16. F. Li PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing Proc. Natl. Acad. Sci. U. S. A. 100 2003 13555 13560
17. J. Zhou The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3′,3′-dimethylsuccinyl}-betulinic acid Retrovirology 1 2004 15
18. V.M. Vogt Proteolytic processing and particle maturation Curr. Top. Microbiol. Immunol. 214 1996 95 131
19. S. Erickson-Viitanen Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease AIDS Res. Hum. Retroviruses 5 1989 577 591
20. H.G. Krausslich Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli J. Virol. 62 1988 4393 4397
21. J. Konvalinka Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases Eur. J. Biochem. 228 1995 191 198
22. R.J. Tritch Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein J. Virol. 65 1991 922 930
23. M.A. Accola A putative α-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly J. Virol. 72 1998 2072 2078
24. K. Wiegers Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites J. Virol. 72 1998 2846 2854
25. J.L. Newman Flexibility in the P2 domain of the HIV-1 Gag polyprotein Protein Sci. 13 2004 2101 2107
26. C. Liang Characterization of a putative α-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag J. Virol. 76 2002 11729 11737
27. J. Zhou Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation J. Virol. 78 2004 922 929
28. B.M. Forshey Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication J. Virol. 76 2002 5667 5677
29. S. Tang Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells J. Virol. 75 2001 9357 9366
30. L. Quere Triterpenes as potential dimerization inhibitors of HIV-1 protease Biochem. Biophys. Res. Commun. 227 1996 484 488
31. C. Tang Antiviral inhibition of the HIV-1 capsid protein J. Mol. Biol. 327 2003 1013 1020
32. M.A. Oliveira The structure of human rhinovirus 16 Structure 1 1993 51 68
33. U.K. von Schwedler Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly EMBO J. 17 1998 1555 1568
34. L. Huang Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action Antimicrob. Agents Chemother. 48 2004 663 665
35. I.C. Sun Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on betulinic acid J. Med. Chem. 45 2002 4271 4275
36. M. Evers Betulinic acid derivatives: a new class of human immunodeficiency virus type 1 specific inhibitors with a new mode of action J. Med. Chem. 39 1996 1056 1068
37. V. Rukachaisirikul Anti-HIV-1 protostane triterpenes and digeranylbenzophenone from trunk bark and stems of Garcinia speciosa Planta Med. 69 2003 1141 1146
38. K. Hirabayashi Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro Chem. Pharm. Bull. (Tokyo) 39 1991 112 115
39. N.P. Sahu Triterpenoid saponins of Mimusops elengi Phytochemistry 41 1996 883 886
40. H.D. Sun Nigranoic acid, a triterpenoid from Schisandra sphaerandra that inhibits HIV-1 reverse transcriptase J. Nat. Prod. 59 1996 525 527
41. S.B. Singh Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products J. Nat. Prod. 66 2003 1338 1344
42. X.W. Yang Anti-HIV-1 protease triterpenoid saponins from the seeds of Aesculus chinensis J. Nat. Prod. 62 1999 1510 1513
43. S. el-Mekkawy Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum Phytochemistry 49 1998 1651 1657
44. H.X. Xu A new anti-HIV triterpene from Geum japonicum Chem. Pharm. Bull. (Tokyo) 48 2000 1367 1369
45. L. Battinelli Effect of limonin and nomilin on HIV-1 replication on infected human mononuclear cells Planta Med. 69 2003 910 913
46. C.M. Ma Inhibitory effects of triterpene-azidothymidine conjugates on proliferation of human immunodeficiency virus type 1 and its protease Chem. Pharm. Bull. (Tokyo) 50 2002 877 880
47. C. Ma Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease Chem. Pharm. Bull. (Tokyo) 47 1999 141 145
48. Y. Kashiwada Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids J. Nat. Prod. 61 1998 1090 1095
49. Y.H. Kuo, and L.M. Kuo Antitumour and anti-AIDS triterpenes from Celastrus hindsii Phytochemistry 44 1997 1275 1281
50. D.F. Chen Novel anti-HIV lancilactone C and related triterpenes from Kadsura lancilimba J. Nat. Prod. 62 1999 94 97